2023 - Research.com Medicine in South Africa Leader Award
2022 - Research.com Medicine in South Africa Leader Award
Robin Wood mainly investigates Acquired immunodeficiency syndrome, Internal medicine, Immunology, Tuberculosis and Sida. His Acquired immunodeficiency syndrome research incorporates elements of Cohort study, Mortality rate, Demography, Viral load and Risk factor. His Mortality rate study combines topics from a wide range of disciplines, such as Pediatrics, Gerontology and Public health.
His Internal medicine research includes elements of Meningitis, Surgery and Gastroenterology. His Immunology research is multidisciplinary, relying on both Pharmacotherapy, Immune reconstitution inflammatory syndrome, Epidemiology and Intensive care medicine. Robin Wood focuses mostly in the field of Tuberculosis, narrowing it down to matters related to Incidence and, in some cases, Opportunistic infection.
Robin Wood mostly deals with Tuberculosis, Acquired immunodeficiency syndrome, Immunology, Internal medicine and Antiretroviral therapy. His biological study spans a wide range of topics, including Incidence, Pediatrics and Disease. His research integrates issues of Developing country, Demography, Cohort study and Cohort in his study of Acquired immunodeficiency syndrome.
Robin Wood has researched Immunology in several fields, including Pharmacotherapy, Epidemiology, Risk factor and Intensive care medicine. The various areas that Robin Wood examines in his Internal medicine study include Gastroenterology, Surgery and Viral load. Robin Wood combines subjects such as Regimen, Reverse-transcriptase inhibitor and Hazard ratio with his study of Viral load.
Tuberculosis, Internal medicine, Mycobacterium tuberculosis, Demography and Viral load are his primary areas of study. His Tuberculosis research includes themes of Incidence, Pediatrics, Disease and Environmental health. Robin Wood studied Incidence and Cohort study that intersect with Epidemiology.
His Internal medicine research is multidisciplinary, incorporating elements of Zidovudine and Antiretroviral therapy. His Viral load study is related to the wider topic of Immunology. His research in Acquired immunodeficiency syndrome tackles topics such as Confidence interval which are related to areas like Cart.
Robin Wood mainly focuses on Tuberculosis, Mycobacterium tuberculosis, Internal medicine, Acquired immunodeficiency syndrome and Young adult. The concepts of his Tuberculosis study are interwoven with issues in Anemia and Hepcidin. His research in Mycobacterium tuberculosis intersects with topics in Transmission, Sputum and Disease, Cause of death.
The study incorporates disciplines such as Resistance, Pharmacology and Antiretroviral therapy in addition to Internal medicine. Robin Wood has included themes like Epidemiology, Cohort study, Hazard ratio, Pediatrics and Triage in his Acquired immunodeficiency syndrome study. His Young adult study incorporates themes from Dolutegravir, Demography and Incidence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
Initiation of antiretroviral therapy in early asymptomatic HIV infection
Sean Emery;Shweta Sharma;Gerd Fätkenheuer;Josep M. Llibre.
The New England Journal of Medicine (2015)
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
P Braitstein;Mwg Brinkhof;F Dabis;M Schechter.
The Lancet (2006)
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study
F van Leth;P Phanuphak;K Ruxrungtham;E Baraldi.
The Lancet (2004)
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.
Stephen D Lawn;Anthony D Harries;Xavier Anglaret;Landon Myer.
Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.
Motasim Badri;Douglas Wilson;Robin Wood.
The Lancet (2002)
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study
Sean Emery;Jacqueline A. Neuhaus;Andrew N. Phillips;Abdel Babiker.
The Journal of Infectious Diseases (2008)
Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.
Stephen D Lawn;Motasim Badri;Robin Wood.
Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
Leigh F. Johnson;Joel Mossong;Rob E. Dorrington;Michael Schomaker.
PLOS Medicine (2013)
Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
Stephen D Lawn;Landon Myer;Linda-Gail Bekker;Robin Wood.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: